This article highlights existing, new, and emerging treatments for the millions of individuals living with acne.

FDA Alerts

FDA Alerts
Friday, July 8, 2016
The FDA approved adapalene gel 0.1% (Differin Gel), a once-daily, over-the-counter, topical gel for the treatment of acne in people 12 years of age or older.
FDA Alerts
Tuesday, April 19, 2016
The FDA Nonprescription Drugs Advisory Committee (NDAC) voted 16-0 on April 15 that adapalene gel 0.1% (Differin Gel), a long-approved prescription topical retinoid for acne is safe for over-the-counter (OTC) use. This recommendation is a first-in-class switch.
FDA Alerts
Tuesday, March 1, 2016
Once-daily dapsone Gel, 7.5% (Aczone, Allergan PlC), a new prescription topical treatment for inflammatory and non-inflammatory acne in patients 12 years of age and older, received FDA approval.
FDA Alerts
Wednesday, February 24, 2016
The FDA will hold a Nonprescription Drugs Advisory Committee meeting on April 15, 2016, from 8 a.m. to 5 p.m. to discuss data submitted by Galderma Laboratories, L.P. to support supplemental new drug application (sNDA) 20-380, for over-the-counter (OTC) marketing of adapalene gel 0.1%.

News

News
Friday, October 20, 2017
A recent study examined the risk of mental health issues in young adults, especially sexual minorities.
News
Friday, July 28, 2017
A generic acne treatment is now available in the United States market.
News
Thursday, July 20, 2017
Researchers recently examined the prevalence of anxiety, depression symptomatology, and suicidal ideation among patients with acne and the impact of this skin condition on the quality of life.
News
Wednesday, June 14, 2017
A recent study examined isotretinoin acne treatment and its impact on the risk of depression in patients.

Research in Review

Research in Review
Friday, October 27, 2017
This article highlights existing, new, and emerging treatments for the millions of individuals living with acne.
Research in Review
Tuesday, January 31, 2017
The condition reduces quality of life, especially in those with disease in exposed areas.
Research in Review
Tuesday, October 18, 2016
The chronic, disabling disease has an unclear pathophysiology and no cure. Early diagnosis is crucial to prevent progression to severe disease.  
Research in Review
Wednesday, January 27, 2016
This articles describes the use of microneedling in a female patient with mild acne scarring.